FDA OKs Medtronic glucose-monitoring device

01/29/2008 | Forbes

The FDA has granted Medtronic approval to market its CGMS iPRO glucose-monitoring device for diabetics. Doctors evaluate the data from the device, which is fastened to a small sensor under the patient's skin, after three days.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN